Modulate Bio
MA - AllstonBiotechnology
Focus: Modulate Bio is a public biotechnology company headquartered in Boston focused on neuromedicines with oncology therapeutic areas. The company operates as a publicly-traded biotech firm.
Profile data last refreshed 4h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
5+5 this month
Growing — net +5 jobs in 30d
5 jobs added vs 0 removed. Steady team buildout.
Should You Work at Modulate Bio?
AI assessmentModulate Bio presents a speculative opportunity for candidates seeking public biotech exposure, but the lack of active pipeline programs and open roles suggests caution regarding career momentum and stability.
Why Work Here
- Public company status provides liquidity and typically more stable equity compensation than private peers
- Focus on neuromedicines and oncology addresses high-need therapeutic areas with strong commercial potential
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Modulate Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.